日付 |
時間 |
ソース |
タイトル |
2024/4/30 | 05:05 | BW | Hyperfine, Inc. to Announce First Quarter 2024 Financial.. |
2024/4/23 | 22:00 | BW | Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen.. |
2024/4/17 | 22:00 | BW | Leading Institutions Enroll First Alzheimer’s Patients.. |
2024/3/22 | 05:05 | GLOBE | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023.. |
2024/3/21 | 20:26 | IHMARKETNEWS | U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs.. |
2024/3/12 | 22:00 | BW | Hyperfine, Inc. Collaborates with King’s College London to.. |
2024/3/08 | 06:30 | BW | Hyperfine, Inc. to Announce Fourth Quarter and Full Year.. |
2024/2/29 | 06:30 | BW | Hyperfine, Inc. to Present at the Oppenheimer 34th Annual.. |
2024/2/21 | 23:00 | BW | Hyperfine, Inc. Announces Collaboration with Athletic Heart.. |
2024/2/17 | 06:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/2/01 | 22:00 | BW | Hyperfine, Inc. Celebrates Breadth of Swoop® System Data.. |
2024/1/09 | 23:00 | BW | Hyperfine, Inc. Launches AI-powered Brain Imaging Software.. |
2023/11/24 | 14:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2023/11/21 | 08:20 | EDGAR2 | Form 3/A - Initial statement of beneficial ownership of.. |
2023/11/20 | 23:00 | BW | Hyperfine, Inc. Announces Presentations on Clinical.. |
2023/11/18 | 09:34 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/11/16 | 23:00 | BW | Hyperfine, Inc. to Present at the Piper Sandler 35th Annual.. |
2023/11/10 | 06:58 | EDGAR2 | Form 8-K - Current report |
2023/11/10 | 06:43 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
2023/11/10 | 06:14 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/11/10 | 06:10 | EDGAR2 | Form 8-K - Current report |
2023/11/10 | 06:05 | GLOBE | Hyperfine, Inc. Reports Third Quarter 2023 Financial Results |
2023/11/02 | 22:15 | BW | Observational Study Finds That Hyperfine, Inc. Portable MR.. |
2023/10/20 | 05:05 | BW | Hyperfine, Inc. to Announce Third Quarter Financial Results.. |
2023/10/11 | 05:05 | BW | Hyperfine, Inc. Announces Promotions of Two Key Clinical.. |
2023/10/09 | 22:00 | BW | Hyperfine, Inc. Receives FDA Clearance for Updated.. |
2023/10/04 | 05:07 | EDGAR2 | Form 8-K - Current report |
2023/9/08 | 05:05 | BW | Hyperfine, Inc. to Present at Gilmartin Group Emerging.. |
2023/8/18 | 05:45 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/8/18 | 05:44 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/8/15 | 05:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/8/15 | 05:11 | EDGAR2 | Form 8-K - Current report |
2023/8/15 | 05:05 | GLOBE | Hyperfine, Inc. Reports Second Quarter 2023 Financial.. |
2023/8/09 | 22:00 | BW | Enrollment Completed for HOPE PMR Pediatric Hydrocephalus.. |
2023/7/25 | 05:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/7/25 | 05:05 | BW | Hyperfine, Inc. to Announce Second Quarter Financial Results.. |
2023/7/19 | 05:19 | EDGAR2 | Form 8-K - Current report |
2023/7/19 | 05:05 | BW | Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D... |
2023/7/11 | 22:00 | BW | Hyperfine, Inc. Launches Observational Study to Define New.. |
2023/6/08 | 22:00 | BW | Hyperfine, Inc. and the International Society for Magnetic.. |
2023/5/18 | 22:00 | BW | Hyperfine, Inc. Receives Grant for an Additional Three Years.. |
2023/5/12 | 05:05 | GLOBE | Hyperfine, Inc. Reports First Quarter 2023 Financial Results |